Proactive Signal Detection and Risk Management in Drug Safety

Signal detection and risk management turn case series, aggregate data, literature, and other sources into validated safety concerns and documented actions. Proactive work means looking before a regulator or competitor forces the question, using qualitative review, statistical methods where appropriate, and clear validation criteria so noise does not become a false crisis or a missed risk. Governance only works if recommendations lead to labeled actions, further study, or a recorded decision to monitor.

Viltis supports signal management processes aligned with GVP and company governance: detection methods, prioritization, validation, assessment, and recommendation for labeling, risk management plan measures, or further study. We help safety and medical teams document decisions in a way that survives audit and inspection, and we connect signals to risk minimization and benefit-risk discussion rather than leaving findings stranded in a tracking spreadsheet. Method choice stays matched to data volume and product risk, not fashion.

Cross-functional signal meetings need a crisp dossier: source data, prior labels, similar cases, and a proposed decision. We help safety teams prepare those packs so medical, regulatory, and commercial stakeholders argue from shared facts. After a decision, we track whether risk minimization or labeling changes were implemented and whether effectiveness checks were scheduled. We also help define when statistical signals require medical validation versus routine monitoring, so resources stay focused. Closed-loop tracking is checked during inspection prep, not invented then.

Signal and risk work we typically support

• Signal detection method and source definition
• Prioritization and validation criteria
• Signal assessment documentation standards
• Linking signals to RMP and labeling actions
• Safety governance meeting preparation
• Tracking of actions and effectiveness checks
• Inspection-facing signal management files

Signal work fails when criteria are vague or actions never close. Viltis keeps the focus on documented medical judgment, clear ownership, and follow-through that matches the risk, not theater metrics that look busy and change nothing. We also help teams prepare for hard questions: what was known when, what was done, and what remains uncertain. If signal trackers are full but actions stall, we help convert open items into governed decisions with owners, due dates, and effectiveness checks.